|
Murdock Research Institute offers free classes (The Salisbury Post)
KANNAPOLIS — The David H. Murdock Research Institute will present a series of free public seminars about how technologies in the Core Lab are used to ...
(Nov 1, 2009)
Of God and Grants (GenomeWeb News)
The blogger at Medical Writing, Editing & Grantsmanship notes that 18,000 applications came in for challenge grants, with 11,000 more in the error correction queue.
(Nov 1, 2009)
UI prof has unique perspective on genome (The Champaign News-Gazette)
URBANA – University of Illinois Professor Richard Powers was doing research for his 10th novel when GQ magazine made him an offer he couldn't refuse. Its editors asked him to have his own genome sequenced and analyzed and to write an article about it. He really didn't want to know his medical future but accepted the assignment; the novel he was working on was about genomics, among other themes.
(Nov 1, 2009)
Guru Stocks at 52-Week Low: GILD, MON, RAH, PCS, LEAP (Guru Focus)
By guruyt. Last week's top five stocks that reached their 52-week lows were Gilead Sciences Inc, Monsanto Company, Ralcorp Holdings Inc, MetroPCS Communications Inc, and Leap Wireless International Inc. According to GuruFocus updates, these Guru stocks have reached their 52-week lows. Read more » »
(Nov 1, 2009)
WCMC-Q's biomedical research program makes significant progress (News-Medical-Net)
The biomedical research program of Weill Cornell Medical College in Qatar has made significant progress in its dual goals of advancing basic science and building a sustainable research community in Qatar since it was launched less than a year and a half ago.
(Nov 2, 2009)
Switching to new immunosuppressant drug may reduce skin cancer after kidney transplantation (News-Medical-Net)
Switching to a newer type of immunosuppressant drug may reduce the high rate of skin cancer after kidney transplantation, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.
(Nov 2, 2009)
MEDomics New MitoDx Test for Mitochondrial Diseases Featured at Major Scientific Meeting in Taiwan (PRWeb via Yahoo! News)
The MitoDx test is much more accurate than any test currently available and will aid in the detection of mitochondrial diseases.
(Nov 2, 2009)
Lupus Drug Shows Promise in New Trial (New York Times)
Human Genome Sciences said early Monday that its experimental drug to treat lupus was effective in its second big clinical trial.
(Nov 2, 2009)
Tumour tissue: who is in control? (Lancet)
Recent developments in genomics have resulted in the increased availability of gene profiles for early diagnosis and prognosis in breast cancer.
(Nov 2, 2009)
NOXXON Pharma commences human dosing in Spiegelmer NOX-A12 clinical trial (News-Medical-Net)
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON’s second drug candidate entering the clinical stage of development within only five months.
(Nov 2, 2009)
As swine flu vaccine runs dry, US wonders 'what if?' (AFP via Yahoo! News)
Mothers with young children and pregnant women are being turned away from swine flu vaccination clinics in the United States, some in tears, many utterly frustrated by the shortage of vaccine.
(Nov 2, 2009)
Arrayit Corporation Blood Tests Diagnose Early Stage Cancers and Communicable Diseases (Marketwire via Yahoo! Finance)
SUNNYVALE, CA--(Marketwire - 11/02/09) - Arrayit Corporation (OTC.BB: ARYC - News ) is pleased to join the federal government in their efforts to help control health care costs by leveraging Arrayit's leading edge health care platform. For more than 150 years, traditional medicine has relied on a 'standards of care' model, which utilizes large cohorts of individuals as the data set and ...
(Nov 2, 2009)
Arrayit Corporation Blood Tests Diagnose Early Stage Cancers and Communicable Diseases (Marketwire)
Collaborative Efforts Leading to Advances That Will Reduce Health Care Costs
(Nov 2, 2009)
GenePattern, DNA Analytics 4.0, SynaWorks, CELS@Home (GenomeWeb News)
The Broad Institute has released GenePattern 3.1 , which includes more than 100 modules for the analysis of gene expression, genetic variation, pathways, and proteomics data.
(Nov 2, 2009)
Calling for an Explanation (GenomeWeb News)
A bunch of bloggers are still waiting on editor-in-chief Michael Dunn's explanation of what occurred during the review and editing process at Proteomics to allow Ward and Han's ' Mitochondria, the missing link between body and soul: Proteomic prospective evidence ' paper to be published.
(Nov 2, 2009)
Institute for Systems Biology to Work With Complete Genomics to Conduct Large-Scale Huntington's Disease Study (Business Wire via Yahoo! Finance)
SEATTLE & MOUNTAIN VIEW, Calif.----The Institute for Systems Biology and Complete Genomics Inc. announced today that they are embarking on a large-scale human genome sequencing study of Huntington’s disease .
(Nov 2, 2009)
Roche Applied Science Announces CGX Arrays Designed by Signature Genomics for Microarray-based Cytogenetic Analysis (Business Wire via Yahoo! Finance)
MADISON, Wis.----Roche Applied Science will announce the European and Asia Pacific launch of the NimbleGen CGX arrays for microarray-based cytogenetic analysis at a workshop series in four European cities and seven cities in Asia Pacific.
(Nov 2, 2009)
FDA Clears SQI's Automated SQiDworks Diagnostics Platform and IgXPLEX Rheumatoid Arthritis Assay for Sale in the ... (PR Newswire via Yahoo! Finance)
SQI Diagnostics Inc. , a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that the U.S. Food and Drug Administration has cleared the Company's automated SQiDworks Diagnostics Platform and its multiplexed IgXPLEX rheumatoid arthritis assay for marketing in the United States.
(Nov 2, 2009)
Patrick Soon-Shiong, MD, and Three Healthcare Companies Win 2009 Innovations in Healthcare Awards (PRWeb via Yahoo! News)
Congratulations to the 2009 "Leadership in Innovation" Award Winner Patrick Soon-Shiong, MD, Chairman and CEO of Abraxis Health, as well as the ABBY Award winners announced at ABL Organization's 11th Annual Innovations in HealthcareSM Awards Event this week. They were: Dakim, Inc.; Epocrates, Inc.; and Osmetech Molecular Diagnostics.
(Nov 2, 2009)
Arrayit Corporation joins federal government in their efforts to help control health care costs (News-Medical-Net)
Arrayit Corporation is pleased to join the federal government in their efforts to help control health care costs by leveraging Arrayit's leading edge health care platform.
(Nov 2, 2009)
US wonders 'what if' (News 24 South Africa)
The new strain of H1N1 flu could have been much more virulent, and it could even have been bird flu.
(Nov 2, 2009)
Study To Evaluate Genetic Risk Factors For Barrett's Esophagus And Esophageal Adenocarcinoma (Medical News Today)
Thomas Vaughan, M.D., head of the Epidemiology Program in the Public Health Sciences Division of Fred Hutchinson Cancer Research Center, has received a three-year, $7.
(Nov 2, 2009)
ISB and Complete Genomics Partner on Huntington's Disease GWAS (GenomeWeb News)
NEW YORK (GenomeWeb News) – The Institute for Systems Biology and Complete Genomics said today that they are conducting a joint large-scale human genome sequencing study of Huntington's disease.
(Nov 2, 2009)
FDA Clears SQI Multiplex Platform, Rheumatoid Arthritis Assay (GenomeWeb News)
NEW YORK (GenomeWeb News) – SQI Diagnostics today said that the US Food and Drug Administration has cleared for marketing its SQiDworks multiplex diagnostics platform and IgXPlex rheumatoid arthritis assay.
(Nov 2, 2009)
Alnylam Releases Preclinical Data Showing Efficacy of TTR Amyloidosis Rx Candidate (GenomeWeb News)
Alnylam Pharmaceuticals today released new preclinical data showing that its TTR amyloidosis drug candidate could trigger dose-dependent reductions of liver TTR messenger RNA and serum TTR protein levels by more than 80 percent in transgenic mice and non-human primates.
(Nov 2, 2009)
ISB and Complete Genomics embark on the largest complete human genome disease association study (News-Medical-Net)
The Institute for Systems Biology (ISB) and Complete Genomics Inc. announced today that they are embarking on a large-scale human genome sequencing study of Huntington’s disease (HD). ISB has engaged Complete Genomics to sequence 100 genomes, the majority of which will be used to investigate this disease, with samples from affected individuals, family members, and matched controls to study ...
(Nov 2, 2009)
Complete Genomics to Sequence 100 Human Genomes for ISB-Led Huntington's Disease Study (GenomeWeb News)
Complete Genomics will sequence 100 human genomes for a study of Huntington's disease led by the Institute for Systems Biology, the partners said today.
(Nov 2, 2009)
Pico-Tesla commences pilot study of its Resonator system for treating type 2 diabetes patients (News-Medical-Net)
Pico-Tesla, The Magneceutical™ Therapy Company, announced today that it has commenced a randomized, double-blind, placebo-controlled Pilot Study of up to 165 persons who have type 2 diabetes, the most common form of diabetes.
(Nov 2, 2009)
A new way of looking at the world (CNN)
What's the first thing that goes through your mind when someone says the word "data"?
(Nov 2, 2009)
To Know Or Not to Know (GenomeWeb News)
People fall into two camps about genetic testing — some people just don't want to know and others are keen to, says Hsien-Hsien Lei at Eye on DNA . She points out a story in the Middletown Journal (Ohio) about a cancer patient who has undergone genetic testing and her family members who are apprehensive about doing it . Another story, Lei points out is that NIH Director Francis Collins was ...
(Nov 2, 2009)
Changing the Way Researchers Are Trained (GenomeWeb News)
"The question is, do we need to rethink how academia functions ?" asks blogger Michael White at Adaptive Complexity. White draws on a recent article from Louis Menand in Harvard Magazine who writes — though he focuses mostly on the humanities — that graduate education is a "lengthy apprenticeship" that doesn't necessarily prepare those students who will be taking jobs outside of academia.
(Nov 2, 2009)
Mildred Cohn Dies (GenomeWeb News)
Mildred Cohn, who pioneered using stable isotopes to trace how enzymes work in cells, has died , reports the Los Angeles Times . She was 96. In addition to her work using stable isotopes to study biochemical reactions, Cohn also used NMR to study the role of ATP as an energy source in the cell.
(Nov 2, 2009)
Lander at the Darwin Conference (GenomeWeb News)
PZ Myers tried to keep up with the Darwin/Chicago 2009 conference on his blog . There, he recounts talks from Jerry Coyne on speciation , Philip Ward on phylogenies , and Eric Lander on genomics and natural selection . At the beginning of Lander's talk, he made the caveat that he wasn't an evolutionist, but rather a biomedical geneticist, which led Myers to comment "as if that was something ...
(Nov 2, 2009)
Monday, November 2, 2009 (GenomeWeb News)
Sometimes you have no idea what you are looking for in a gene expression study. You just want to see what is going on and don't want to be limited to what's already known — those unknown genes can have interesting activity too. In that case, an RNAseq experiment might be for you.
(Nov 2, 2009)
Monday, November 2, 2009 (GenomeWeb News)
In this issue of GT , we bring you our ninth technical guide on real-time PCR. While it seems like not so long ago that we laid the first troubleshooting lab manual in your hands, the field has advanced, especially in the areas of quality control, experimental design, and data analysis.
(Nov 2, 2009)
Recent Patents of Interest in Proteomics (GenomeWeb News)
US Patent 7,605,003. Use of biomarkers for detecting ovarian cancer . Inventors: Daniel Chan; Zhen Zhang; Eric Fung; Xiao-Ying Meng. Assignees: Johns Hopkins University; Vermillion
(Nov 2, 2009)
Quest to Offer Septin9 Colorectal Cancer LTD 'Later This Year' (GenomeWeb News)
Quest "later this year" plans to begin offering a Septin9 homebrew test for colorectal cancer based on Epigenomics’ mSEPT9 DNA-methylation biomarker, a senior Quest official said today.
(Nov 2, 2009)
Genomics: No Longer A Failure (Forbes)
Mapping the human genome produced far more hype than drugs. That's starting to change.
(Nov 2, 2009)
Hutchinson Center Using $8M Grant for Esophageal Cancer Genomics (GenomeWeb News)
NEW YORK (GenomeWeb News) – The Fred Hutchinson Cancer Center has received a $7.9 million grant from the National Cancer Institute to lead a genomics study aimed at finding risk genes for Barrett's esophagus and esophageal adenocarcinoma, a fatal cancer that has increased in incidences 500 percent in the past 30 years.
(Nov 2, 2009)
High-throughput genotyping, protein purification featured in Cold Spring Harbor Protocols (EurekAlert!)
( Cold Spring Harbor Laboratory ) High-throughput genotyping and protein purification methods are featured in the November issue of Cold Spring Harbor Protocols.
(Nov 2, 2009)
AACC Grants Proteomics Permanent Status, Signaling Growing Value within Clinical Chemistry (GenomeWeb News)
In a move suggesting the growing importance of proteomics in the clinical chemistry arena — and vice versa — the American Association for Clinical Chemistry has made proteomics a permanent division, starting on Jan. 1, 2010.
(Nov 2, 2009)
Papers of Note (GenomeWeb News)
Mahal's lab is focused on the role of glycosylation in myriad biological processes including bacterial pathogenesis, cell signaling, tumor cell metastasis, and neuronal development. Her lab is attempting to develop chemical, biological, and systems-based methods to aid in this research.
(Nov 2, 2009)
Mike Snyder, Personalized Medicine, Open Access, SBGN, and the 1,000 Genomes Project (GenomeWeb News)
In Genome Technology 's cover story five years ago, we looked into the tech transfer process, with our cover image showing off Mike Snyder, who worked with the Yale tech transfer group to start his company Protometrix. The startup was acquired by Invitrogen not long after the story ran.
(Nov 2, 2009)
ISB Identifies Candidate Disease Genes with Complete Genomics Data (GenomeWeb News)
Scientists from the Institute for Systems Biology analyzed the genomes of a four-member family sequenced by Complete Genomics and pinpointed three candidate disease genes for the children, who suffer from rare Mendelian disorders.
(Nov 3, 2009)
The University Times | The University of North Carolina at Charlotte's Student Newspaper Since 1949 (Niner Online)
As a student of UNC Charlotte, what does the word ‘expansion’ mean to you? Do you think about the constant construction, the need for more parking, or the limited amount of on-campus housing?
(Nov 3, 2009)
Pregnant women tolerate the 2009 H1N1 flu vaccine, mount strong immune response (News-Medical-Net)
Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.
(Nov 3, 2009)
Roche Applied Science to launch the NimbleGen CGX arrays in Europe and Japan (News-Medical-Net)
Roche Applied Science will announce the European and Asia Pacific launch of the NimbleGen CGX arrays for microarray-based cytogenetic analysis at a workshop series in four European cities and seven cities in Asia Pacific. The CGX arrays are designed by Signature Genomic Laboratories (Signature Genomics) and provide high-resolution, genome-wide analysis of chromosomal abnormalities.
(Nov 3, 2009)
Celera licenses lung cancer intellectual property from Medical Therapies (PharmaBiz)
Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited, a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY’s midkine patent portfolio for the development of novel lung cancer diagnostics.
(Nov 3, 2009)
NuGEN Announces the Newest Member of its Applause Product Family (Business Wire via Yahoo! Finance)
SAN CARLOS, Calif.----NuGEN Technologies, Inc., a pace-setter in nucleic acid sample preparation, introduces the Applause 3'-Amplification System, a fast, cost-effective, single-tube solution to prepare RNA samples for microarray gene expression studies.
(Nov 3, 2009)
Rosetta Genomics Names Kenneth A. Berlin President and Chief Executive Officer (Business Wire via Yahoo! Finance)
REHOVOT, Israel & PHILADELPHIA----Rosetta Genomics, Ltd. , a leading developer of microRNA-based molecular diagnostics, today announced the appointment of Kenneth A. Berlin to the position of president and chief executive officer, effective November 2, 2009.
(Nov 3, 2009)
|
